<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib50">
 <element-citation publication-type="journal" id="sref50">
  <person-group person-group-type="author">
   <name>
    <surname>Meng</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Qin</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Luo</surname>
    <given-names>J.</given-names>
   </name>
  </person-group>
  <article-title>An experimental trial of recombinantX human interferon alpha nasal drops to prevent coronavirus disease 2019 in medical staff in an epidemic area</article-title>
  <source>MedRxiv</source>
  <year>2020</year>
  <comment>Available from:</comment>
  <ext-link ext-link-type="uri" xlink:href="https://www.medrxiv.org/content/10.1101/2020.04.11.20061473v2" id="intref0020a" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.medrxiv.org/content/10.1101/2020.04.11.20061473v2</ext-link>
  <comment>(last accessed on 24th August 2020)</comment>
 </element-citation>
</ref>
